GH Research PLC GHRS
GHRS
GH Research PLC ABUS
Arbutus Biopharma Corporation VALN
Valneva SE PVLA
Palvella Therapeutics, Inc. KURA
Kura Oncology, Inc. AVBP
ArriVent BioPharma, Inc. Common Stock AVXL
Anavex Life Sciences Corp. GERN
Geron Corporation BBOT
BridgeBio Oncology Therapeutics Inc. AKBA
Akebia Therapeutics, Inc.
GH Research PLC ABUS
Arbutus Biopharma Corporation VALN
Valneva SE PVLA
Palvella Therapeutics, Inc. KURA
Kura Oncology, Inc. AVBP
ArriVent BioPharma, Inc. Common Stock AVXL
Anavex Life Sciences Corp. GERN
Geron Corporation BBOT
BridgeBio Oncology Therapeutics Inc. AKBA
Akebia Therapeutics, Inc.
Performance
| Periode | GHRS | ABUS | VALN | PVLA | KURA | AVBP | AVXL | GERN | BBOT | AKBA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 50.21 % | 35.87 % | 31.72 % | 177.39 % | 71.70 % | -6.39 % | -9.87 % | -9.86 % | 2.72 % | 33.19 % |
| YTD | 80.97 % | 35.87 % | 96.19 % | 486.92 % | 27.19 % | -29.05 % | -30.12 % | -64.44 % | 2.91 % | 66.84 % |
| 1Y | 77.61 % | 10.37 % | 52.05 % | 314.29 % | -37.73 % | -39.42 % | 46.89 % | -69.67 % | 7.71 % | 94.48 % |
| 3Y | 45.33 % | 90.21 % | -30.73 % | 314.29 % | -28.40 % | -2.55 % | -27.31 % | -44.35 % | 10.99 % | 1 065.44 % |
| 5Y | -25.64 % | 54.67 % | -64.94 % | 314.29 % | -65.80 % | -2.55 % | 49.74 % | -30.81 % | 10.99 % | 30.99 % |
| 10Y | -25.64 % | -25.99 % | -64.94 % | 314.29 % | -31.00 % | -2.55 % | -6.70 % | -62.90 % | 10.99 % | -65.54 % |
| Depuis le début | -25.64 % | -29.05 % | -64.94 % | 314.29 % | -26.40 % | -2.55 % | 6.13 % | -82.54 % | 10.99 % | -88.13 % |